Solid Tumors
Stay up to date on the latest advances in malignant solid tumor management with a focus on the role of the advanced practitioner on the multidisciplinary team.
Breast Cancer 57 results
Beyond Standard Endocrine Therapy: A New Adjuvant Treatment in High-Risk Early Breast Cancer
By Barbara Dean, DMSc, PA-C, DFAAPA
July 22, 2024
Improving Outcomes for Women With Metastatic HER2-Positive and HER2-Low Breast Cancer
Presented by Stephanie L. Graff,(1,2) MD, FACP, FASCO, Christine McGinn,(1) MSN, APRN, ACNP-BC, and Jeanine R. Showalter,(3) MSN, APRN, FNP-BC, AOCNP®
April 17, 2024
Practical Management of Adverse Events Associated With FGFR Inhibitors for Cholangiocarcinoma for the Advanced Practice Provider
By Gabriel Schwartz, MSN, FNP-BC, AOCNP, Julianne O. Darling, PharmD, BCOP
February 14, 2024
Precautions for Patients Taking Tamoxifen or Aromatase Inhibitors
Mary Heery, APRN, AOCNS®, CBCN
September 18, 2023
Quality of Life in Adult Cancer Patients With Underage Children: An Integrative Review
Gabriela Mota-George, MSN, APRN, FNP-BC, AOCNP®, Ashley Martinez, DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP
July 17, 2023
Advancing the Care of Women With HER2-Positive Metastatic Breast Cancer
Presented by Marcie Beasley, FNP-C, AOCNP®, and Brooke Daniel, MD
April 26, 2023
Managing the Patient With Multiple Primary Tumors
Presented by Holly Chitwood, DNP, APRN, FNP, AGACNP, and Tamara Carey, MSN, APRN, FNP
April 24, 2023
Meta-Analysis of Same-Day Pegfilgrastim Administration Stratified by Myelotoxic Febrile Neutropenia Risk and Tumor Type
Neda Alrawashdh,(1,2) PhD, PharmD, Ali McBride,(3) PharmD, MS, BCPS, Mok Oh,(1) PhD, PharmD, Nimer Alkhatib,(1) PhD, PharmD, Christopher Lee,(4) PhD, RN, FAHA, FAAN, FHFSA, Jennifer Martin,(5) MA, Karen MacDonald,(6) PhD, RN, and Ivo Abraham,(1,3,6) PhD, RN
November 21, 2022
Timely Genetic Testing and Therapy Management in Patients With gBRCA-Mutated Metastatic Breast Cancer Receiving Talazoparib
Ashley Martinez,(1) DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, Tiffany Jones,(2) MSN, ACNP-BC, Joanne C. Ryan,(3) PhD, RN, Chad M. Barnett,(3) PharmD, BCOP, Elpitha L. Soussou,(3) PharmD, MBA, and Sarah Donahue,(4) MPH, NP, AOCNP®
September 20, 2022
Breast Cancer: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
Jacquelyn Lauria, RN, APN, AOCNP® and Rose DiMarco, PharmD, BCPS, BCOP
August 23, 2022
Immunotherapy for the Treatment of Triple-Negative Breast Cancer
Sara M. Tolaney, MD, MPH, and Lindsay Shaw, ANP-BC, AOCNP®
April 21, 2022
Sacituzumab Govitecan for Treatment of Refractory Triple-Negative Metastatic Breast Cancer
Patrick J. Fleming Jr., PharmD, BCOP, Sylvia Karpio, PharmD candidate, and Nicholas Lombardo, PharmD candidate
September 22, 2021
Other Solid Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Abby Fuoto, DNP, ANP-BC, AOCNP®, ACHPN and Mee-young Lee, MSN, ANP-BC
August 25, 2021
Breast Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Sheeba Cantanelli, MPAS, PA-C
August 24, 2021
Nipple-Sparing Mastectomy in Breast Cancer: Impact on Surgical Resection, Oncologic Safety, and Psychological Well-Being
Lisa Parks, MS, APRN-CNP, ANP-BC
July 12, 2021
Ribociclib and Abemaciclib: CDK4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Metastatic Breast Cancer
Kristina F. Byers, PharmD, BCOP
January 20, 2021
Development, Implementation, and Patient Perspectives of the Women’s Integrative Sexual Health Program: A Program Designed to Address the Sexual Side Effects of Cancer Treatment
Lori A. Seaborne, MPAS, PA-C, Megan Peterson, DNP, David M. Kushner, MD, Janelle Sobecki, MD, MA, and Joanne K. Rash, MPAS, PA-C
January 19, 2021
Oncology Advanced Practitioners and Breast Cancer Prevention
Wendy H. Vogel,(1) MSN, FNP, AOCNP®, Haley Pace,(2) MS, CGC, and Matthew Brignola,(3) PharmD
November 18, 2020
Optimizing Palbociclib Therapy Across the Age Spectrum: Hypothetical, Illustrative Case Scenarios in HR+, HER2– Metastatic Breast Cancer
Kimberly Podsada,(1) MSN, NP-C, Joanne C. Ryan,(2) PhD, RN, and Kristi Orbaugh,(3) RN, MSN, RNP, AOCN®
September 23, 2020
Alpelisib: A Novel Therapy for Patients With <em>PIK3CA</em>-Mutated Metastatic Breast Cancer
Tori Wilhoit, PharmD, Jeannie M. Patrick, PharmD, BCOP, and Megan B. May, PharmD, BCOP
September 23, 2020
Breast Cancer: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner
Paula Anastasia,(1) RN, MN, AOCN®, and Wendy H. Vogel,(2) MSN, FNP, AOCNP®
August 26, 2020
A Patient-Centered Approach for the Treatment of Fungating Breast Wounds
Karlyn L. Rupert, MPAS, PA-C, and Andrea J. Fehl, CRNP, AOCNP®
July 22, 2020
Larotrectinib and Entrectinib: TRK Inhibitors for the Treatment of Pediatric and Adult Patients With NTRK Gene Fusion
Danielle B. Dunn, PharmD
May 27, 2020
Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices
Presented by Jame Abraham, MD, and Kelley D. Mayden, MSN, FNP, AOCNP®
April 21, 2020
Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
Presented by Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®
April 21, 2020
Precautions for Patients Taking Aromatase Inhibitors
Mary Heery,(1) APRN, AOCNS®, CBCN, Stephen Farley,(2) PharmD, BCOP, Rhett Sparkman,(2) PharmD, John Healy, BS, Pharmd, William Eighmy,(3) PharmD, George Zahrah,(2) MD, and Richard Zelkowitz,(1) MD
March 18, 2020
A Tale of Two Sisters: Breast Reconstruction Options for Women With or at High Risk of Breast Cancer
Kathryn Trotter,(1) DNP, CNM, FNP, FAAN, Jennifer K. Plichta,(2) MD, MS, FACS, and Michael Zenn,(3) MD, MBA, FACS
March 13, 2020
Advances in Oral Oncolytic Agents for Breast Cancer and Recommendations for Promoting Adherence
Theresa Wicklin Gillespie, RN, MA, PhD, FAAN
January 22, 2020
Metabolic Syndrome, Exercise, and Cardiovascular Fitness in Breast Cancer Survivors
M. Tish Knobf, PhD, RN, AOCN®, FAAN, and Sangchoon Jeon, PhD
January 22, 2020
Dihydropyrimidine Dehydrogenase Deficiency: To Screen or Not to Screen?
Wendy H. Vogel,(1) MSN, FNP, AOCNP®, Ahmed Minhas,(2) MD, and Steven Baumrucker,(1) MD
January 21, 2020
Treatment of Pregnancy-Associated Breast Cancer
Bernadette Labriola, RN, MSN, FNP-C
September 18, 2019
2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Breast Cancer
Wendy H. Vogel, MSN, FNP, AOCNP®
August 21, 2019
Breast Cancer in the Transgender Population
Andrea Fehl,(1) FNP-C, MSN, AOCNP®, Shannon Ferrari,(1) PA-C, MPAS, Zoe Wecht,(1) BS, and Margaret Rosenzweig,(2) PhD, FNP-C, AOCNP®, FAAN
May 21, 2019
Advances in the Treatment of HER2-Positive Breast Cancer
Presented by Reshma Mahtani, DO, and Lisa Hineman, MS, AOCN®, PHN, ANP-C
April 22, 2019
Surgical Implications for Women With Breast Cancer
Presented by Sherry Goldman, MSN, NP, CBCN
April 22, 2019
Advances in HER2-Positive Breast Cancer: Novel Therapies and Adverse Event Management
Reshma Mahtani, DO, and Lisa Hineman, MS, AOCN®, PHN, ANP-C
March 24, 2019
Olaparib: A Novel Therapy for Metastatic Breast Cancer in Patients With a BRCA1/2 Mutation
Sarah E. Caulfield, PharmD, BCOP, Christine C. Davis, PharmD, BCOP, and Kristina F. Byers, PharmD, BCOP
March 24, 2019
Neratinib for the Treatment of Early-Stage HER2-Positive Breast Cancer
Jennifer Miles, PharmD, and Yahsin White, PharmD
November 27, 2018
Enhanced Recovery After Surgery
Lisa Parks,(1) MS, RN, CNP, Meghan Routt,(2) MSN, ANP/GNP-BC, AOCNP®, and Allison De Villiers,(1) MSN, RN, OCN®, ACNS-BC
July 24, 2018
Current Issue
How Do We Achieve Value-Based, Patient-Centered Care?
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
September 16, 2024
Is it Cellulitis Again? Erythema Concerning for Infection in Children With High-Risk Solid Tumors Who Have a Gastrostomy Tube
Kristen L. Dalton, MSN, RN, CPNP-AC, CPHON, Meredith R. Johnson, MSN, RN, CRNP-AC
September 16, 2024
Carcinoid Heart Disease
Nicole Kuhnly, MS, ACNPC-AG, Jessica Shank Coviello, DNP, APRN, ANP-BC, Catherine A. Kobza, MSN, AGACNP-BC, Et al.
September 16, 2024